TrialA Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)
Trial details
- Registry ID
- NCT06616974
- Phase
- Phase 2
TECX
Tectonic Therapeutic
Company identity has not yet been verified
Browse linked trials and recorded changes, or follow this company for updates.
1Trials in this database
3Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity source| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)NCT06616974 | Tectonic Therapeutic | Phase 2 | Active not recruiting | 2026-11-24Estimated |
Latest recorded trial changes
A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)
NCT06616974 · Tectonic Therapeutic
Planned enrollment increased by 11 participants
− Before
180 participants (planned)
+ After
191 participants (planned)
Primary completion date changed
− Before
9 Oct 2026
+ After
24 Nov 2026
Recruitment status changed
− Before
Recruiting
+ After
Active not recruiting